| scholarly article | Q13442814 |
| P2093 | author name string | Maria J Worsham | |
| Josena K Stephen | |||
| Kang Mei Chen | |||
| Usha Raju | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation | Q24297959 | ||
| Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification | Q24530153 | ||
| Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences | Q24813458 | ||
| Worms gang up on bacteria | Q27860588 | ||
| Quantitative assessment of promoter hypermethylation during breast cancer development | Q30811494 | ||
| Circulating tumor markers in breast cancer: accepted utilities and novel prospects | Q33538453 | ||
| Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer | Q33645338 | ||
| Cytosine methylation and human cancer | Q33845225 | ||
| DNA methylation: an alternative pathway to cancer | Q34290123 | ||
| DNA methylation in breast cancer | Q34304102 | ||
| DNA methylation and breast carcinogenesis. | Q34770599 | ||
| Molecular classification of breast carcinoma in situ | Q35690193 | ||
| Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis | Q35933390 | ||
| In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis | Q36555603 | ||
| An epigenetically derived monoclonal origin for recurrent respiratory papillomatosis | Q38431283 | ||
| Establishing a molecular continuum in breast cancer DNA microarrays and benign breast disease. | Q38458380 | ||
| Epigenetic events of disease progression in head and neck squamous cell carcinoma | Q40265610 | ||
| High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. | Q40345520 | ||
| Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. | Q41628042 | ||
| Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia | Q43919102 | ||
| Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk | Q45238905 | ||
| DNA methylation in benign breast epithelium in relation to age and breast cancer risk | Q46593260 | ||
| Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers | Q48277606 | ||
| Carcinoembryonic antigen: an invaluable marker for advanced breast cancer. | Q50869251 | ||
| Premalignant and in situ breast disease: biology and clinical implications. | Q53354188 | ||
| Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. | Q53429823 | ||
| Detection of Tumor Markers Including Carcinoembryonic Antigen, APC, and Cyclin D2 in Fine-Needle Aspiration Fluid of Breast. | Q53861430 | ||
| The fundamental role of epigenetic events in cancer | Q56421597 | ||
| Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma | Q57161281 | ||
| Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma | Q73696172 | ||
| Expression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis | Q78082457 | ||
| Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma | Q79912960 | ||
| Identification of individual genes altered in squamous cell carcinoma of the vulva | Q80342475 | ||
| [Methylation status and protein expression of adenomatous polyposis coli (APC) gene in breast cancer] | Q80464114 | ||
| Epigenetic events underlie the pathogenesis of sinonasal papillomas | Q80731971 | ||
| DNA methylation and cancer | Q81002014 | ||
| Multiplicity of benign breast lesions is a risk factor for progression to breast cancer | Q81310365 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1580-1592 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Delineating an epigenetic continuum for initiation, transformation and progression to breast cancer | |
| P478 | volume | 3 |
| Q36010918 | A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis |
| Q35846508 | Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies. |
| Q36091457 | Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies |
| Q37308097 | DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study |
| Q38012175 | Epigenetics of estrogen receptor-negative primary breast cancer |
| Q35806601 | Genetic risk variants associated with in situ breast cancer |
| Q54317130 | Methylation biomarkers for pleomorphic lobular breast cancer - a short report. |
| Q89834368 | Nutrigenomics and Breast Cancer: State-of-Art, Future Perspectives and Insights for Prevention |
| Q36607318 | Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study |
| Q35866022 | Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases. |
Search more.